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Abstract
OBJECTIVE: To investigate the clinical differentia-
tion of spleen-deficiency pattern (SDP), a group of
symptoms and signs defined in terms of Traditional
Chinese Medicine for its clinical practice.
METHODS: Peripheral venous blood (> 3 mL) was
collected from each of six type 2 diabetes mellitus
(T2DM)-SDP patients and six healthy volunteers. Af-
ter the isolation of peripheral white blood cells (PW-
BCs), total RNA was extracted, and quality control
was performed on all RNA samples. Microarray ex-
periments were conducted using the Agilent hu-
man whole genome gene chip, and genes demon-
strating differential expression were screened. Bio-
informatics analysis was conducted on these genes
using several online databases.
RESULTS: We screened a total of 175 differentially
expressed genes (DEGs), of which 111 (63%) were
down-regulated and 64 (37%) were up-regulated in
T2DM-SDP patients compared with healthy con-
trols. Among the 175 genes, 158 had biological
function annotations: 46 (29%) were directly relat-
ed to an individual's immune regulation or re-
sponse, 25 (16% ) were associated with substance
and energy metabolism of PWBCs which could also
indirectly influence immunity, and the remaining
87 (55%) were involved in a variety of PWBC biolog-
ical processes that might eventually influence the
immune function. Kyoto Encyclopedia of Genes
and Genomes pathway enrichment analysis re-
vealed that the DEGs were predominantly enriched
in seven immune-related pathways. Hierarchical
cluster analysis identified gene expression patterns
that were distinguishable between the two study
groups.
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CONCLUSION: Our results suggest that T2DM-SDP
patients experience significant hypoimmunity and/
or immune dysfunctions, and possess a specific
gene expression profile. These findings offer new
insights into SDP and the clinical pattern differenti-
ation of T2DM-SDP.
© 2015 JTCM. All rights reserved.
Key words: Diabetes mellitus, Type 2; Immunity;
Metabolism; Leukocytes; Oligonucleotide array se-
quence analysis; Spleen-deficiency pattern
INTRODUCTION
Traditional Chinese Medicine (TCM) characterizes the
spleen as an organ of comprehensive function associat-
ed with a number of biological systems including the
immune system. Spleen-deficiency pattern (SDP) is a
group of symptoms and signs defined by TCM clinical
practice in terms of its theory. SDP is one of the most
commonly encountered patterns in TCM practice and
often involves immune dysfunction as well as disorders
of the digestive system.
The occurrence and development of SDP is believed to
have its own genomic basis.1 Indeed, we previously
showed that the differential gene profile of SDP pa-
tients (those with chronic gastritis and ulcerative coli-
tis) was mainly associated with pathways of substance
and energy metabolism and immune regulation, and
that gene expression tended to be down-regulated com-
pared with healthy controls.2-6 These findings were also
determined in a previous gene array study on peripher-
al white blood cells (PWBCs) from chronic gastritis
and ulcerative colitis patients with SDP.7 However,
gene array studies on SDP have certain limitations, in-
cluding a restriction of disease entities and tissue sources.
SDP is recognized by TCM as one of the primary
causes for the occurrence and development of type 2 di-
abetes mellitus (T2DM).8,9 Thus, the present study
aimed to investigate the differential gene profile of PW-
BCs in T2DM-SDP patients to provide new insights
into SDP clinical pattern differentiation.
MATERIALS ANDMETHODS
Recruitment of participants
Patients were included in the study if they met the fol-
lowing criteria: (a) were clinically diagnosed with
T2DM (see below), (b) met the TCM pattern identi-
fied as SDP (see below), (c) were aged between 35 and
70 years, and (d) had signed the informed consent
form. Exclusion criteria were as follows: (a) diagnosed
with other endocrine diseases in addition to T2DM, or
suffering severe complications caused by T2DM, (b)
having infectious or inflammatory diseases, (c) having
psychiatric or serious somatic diseases, (d) having dys-
lipidemia, and (e) pregnant or breastfeeding.
The T2DM diagnostic standard according to the Amer-
ican Diabetes Association is as follows:10 (a) a fasting
plasma glucose level ≥ 126 mg/dL (7.0 mmol/L), or
(b) a 2-h plasma glucose level ≥ 200 mg/dL (11.1 mmol/
L) during a 75 g oral glucose tolerance test, or (c) a ran-
dom plasma glucose level ≥ 200 mg/dL (11.1 mmol/L)
combined with classic symptoms of hyperglycemia or
hyperglycemic crisis. The diagnostic standard of SDP
has been established in the Guiding Principle of Clini-
cal Research on New Drugs of Chinese Medicine.11
The dominant symptoms are: (a) a pale tongue with a
thin-white coating, (b) poor appetite, (c) abdominal
distension, and (d) loose stools or diarrhea. The second-
ary symptoms are: (a) thinness, (b) weakness, and (c) a
weak pulse. Possession of a pale tongue with a thin-white
coating is essential for a diagnosis of SDP, and this
should be combined with two of the other three dom-
inant symptoms, or combined with one of the others
and at least two of the secondary symptoms. Pattern
differentiation was performed by two of the authors
(Chen Longhui and Zhu Zhangzhi), and disagree-
ment was resolved by discussion with Chen Weiwen.
Healthy volunteers aged between 35 and 70 years were
interviewed by one of the authors (Chen Ruifang). The
volunteers were free of endocrine diseases including
T2DM, infectious and inflammatory diseases, psychiat-
ric and serious somatic diseases, and dyslipidemia.
They also had no apparent TCM patterns, and a nor-
mal tongue and pulse. Those who did not sign the in-
formed consent form were excluded from the study.
We finally included 12 participants, of whom six were
categorized as T2DM-SDP patients and six as healthy
volunteers, from the First Affiliated Hospital of Guang-
zhou University of Chinese Medicine from October
2013 to December 2013. In the T2DM-SDP patients
(three women and three men), the average age was
58.7 years (range, 48-67 years). In the healthy volun-
teers (three women and three men), the average age
was 59.5 years (range, 50-65 years). No significant dif-
ferences were observed between the two study groups
regarding sex and age.
RNA isolation and quality control
Venous blood (> 3 mL) was collected from each fast-
ing participant in the morning. EDTA (Beyotime In-
stitute of Biotechnology, Shanghai, China) was intro-
duced for anticoagulation. After separation, PWBCs
were added to an appropriate volume of TRIzol (Invi-
trogen, Carlsbad, CA, USA) to achieve cell lysis. To-
tal RNA was then isolated using the mirVana™ RNA
Isolation Kit (Applied Biosystems, Foster City, CA,
USA) according to the manufacturer's instructions.
After quantification using a NanoDrop ND-2000
spectrophotometer (Thermo Scientific, Waltham,
MA, USA), we used the Agilent Bioanalyzer 2100
(Agilent Technologies, Santa Clara, CA, USA) to de-
tect the RNA Integrity Number (RIN) for RNA
quality control.12
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Microarray Microarray experiments and screening of
differentially expressed genes (DEGs) were conducted
in the central laboratory of Shanghai OE Biotech Co.,
Ltd. (Shanghai, China). We used the Agilent SurePrint
G3 Human Gene Expression 8 × 60k v2 Microarray
kit (Design ID: 039494; Agilent Technologies, Shang-
hai, China), which included a chip that could simulta-
neously detect expression level changes of 30 000 pro-
tein-coding Entrez Gene RNAs and 12 000 long inter-
genic non-coding RNAs.
Sample labeling, microarray hybridization, and wash-
ing were performed according to the manufacturer's in-
structions. Briefly, total RNA was transcribed to dou-
ble-stranded cDNA, then synthesized into cRNA and
labeled with cyanine 3-CTP. The labeled cRNAs were
then hybridized onto the microarray. After washing,
the arrays were scanned by the Agilent Scanner
G2505C (Agilent Technologies).
Screening of differentially expressed genes
Feature Extraction software (version 10.7.1.1; Agilent
Technologies, Shanghai, China) was used to analyze
array images to obtain raw data. Raw data were nor-
malized with the quantile algorithm, then Gene-
Spring software (version 12.5; Agilent Technologies,
Shanghai, China) was used to complete the basic
analysis. Probes that 100% of the values in at least
one out of all conditions have flags in "Detected"
were chosen for further data analysis. Genes that
were differentially expressed between T2DM-SDP pa-
tients and healthy volunteers were identified through
fold-changes as well as P values calculated using the
t-test. The threshold for up- and down-regulated
genes was a fold-change³ 2.0 and a P value ≤ 0.05.
A negative value of fold-change was considered to
represent a down-regulated gene, while a positive val-
ue represented an up-regulated gene.
Bioinformatics analysis of differentially expressed
genes
Several free online databases, including GenBank, Gen-
eCard, and DAVID, were used to annotate informa-
tion about DEGs. We also performed Kyoto Encyclo-
pedia of Genes and Genomes (KEGG) pathway enrich-
ment analysis of DEGs using the FunNet tool (www.
funnet.info). The significance of gene enrichment of
the considered KEGG category or annotation cluster
was calculated using Fisher's exact test. A P value <
0.05 was considered significant. MeV version 4.6 soft-
ware (Dana-Farber Cancer Institute, Boston, MA,
USA) was used to perform hierarchical cluster analysis
of DEGs to reveal distinguishable gene expression pat-
terns between the two study groups.
RESULTS
RNA quality control
An Agilent Bioanalyzer 2100 was used to detect RIN
for RNA quality control. We would discard those sam-
ples that failed to meet the standard of RIN ≥ 7.0
and 28 S / 18 S > 0.7. Fortunately, all RNA samples of
the participants tested passed the strict quality con-
trol (Figure 1).
Screening of differentially expressed genes between
T2DM-SDP patients and healthy volunteers
The six healthy volunteers served as the control group.
We screened genes expressed differentially between
T2DM-SDP patients (1-6) and healthy volunteers
(7-12). These findings were represented in a volcano
plot (Figure 2), in which the log2 (fold-change) is
shown on the x-axis and the -log10 (P value) is shown
on the y-axis. Both DEGs and differentially expressed
non-coding RNAs (ncRNAs) are marked in red.
A total of 175 DEGs were identified between the two
study groups, of which 111 (63%) were down-regulat-
ed and 64 (37%) were up-regulated in T2DM-SDP pa-
tients compared with healthy volunteers. Of the 175
genes, 158 (90%) had biological function annotations.
We also obtained 138 differentially expressed ncRNAs,
of which 76 (55%) were down-regulated and 62 (45%)
up-regulated in T2DM-SDP patients compared with
healthy volunteers. None of the ncRNAs had biologi-
cal function annotations, so they were not investigated
further in the present study.
Figure 1 Electrophoresis of RNA samples
1-6: healthy volunteers 1-6; 7-12: T2DM-SDP patients 7-12; ladder: RNA maker. T2DM-SDP: type 2 diabetes mellitus with spleen-de-
ficiency pattern.
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Annotations of differentially expressed genes between
T2DM-SDP patients and healthy volunteers
Among the 158 annotated genes, 46 (29%) were direct-
ly related to PWBC immune regulation or the immune
response. Of these, 27 genes were down-regulated and
the remaining 19 were up-regulated in T2DM-SDP pa-
tients compared with controls (Table 1). The CCL23
protein demonstrates chemotactic activity for mono-
cytes, resting T lymphocytes, and neutrophils.13 Thus,
the down-regulation (P = 0.0003, fold-change =
－5.5459) of CCL23 might be responsible for the ob-
served hypoimmunity of T2DM-SDP patients.
We also identified 25 DEGs (16%) that were related to
substance and energy metabolism of PWBCs, of which
18 were down-regulated and seven up-regulated in
T2DM-SDP patients compared with controls (data
not shown). These gene products could also indirectly
influence the immunity of an individual. For example,
the protein encoded by the prostaglandin-endoperox-
ide synthase 2 gene (PTGS2) mediates the formation
of prostaglandins from arachidonate, and may have a
role as a major mediator of inflammation.14 Thus the
down-regulation of PTGS2 (P = 0.0004, fold-
change = －2.6323) in T2DM-SDP patients might al-
so contribute to their immune dysfunction.
The remaining 87 DEGs were shown to be involved in
a wide variety of PWBC biological processes, including
transcriptional regulation, DNA repair and replication,
chromosomal stability and segregation, cell cycle pro-
gression, cell proliferation and differentiation, apopto-
sis, cell-cell communication, and cell motility (data not
shown). Abnormal expression of these genes might also
influence the immune functions of individuals.
KEGG pathway enrichment analysis of differentially
expressed genes between T2DM-SDP patients and
healthy volunteers
We next performed KEGG pathway enrichment analy-
sis using the FunNet tool. As shown in Table 2 and Fig-
ure 3, DEGs were predominantly enriched in the fol-
lowing pathways: cytokine-cytokine receptor interac-
tion (44.4% ), natural killer cell-mediated cytotoxicity
(33.3%), chemokine signaling pathway (27.8%), anti-
gen processing and presentation (27.8%), hematopoiet-
ic cell lineage (22.2%), complement and coagulation cas-
cades (16.7%), and graft-versus-host disease (16.7%).
All of these pathways are related to immune regulation
or response. We also investigated the number of anno-
tated genes with respect to KEGG category or annota-
tion cluster, and found that most of the enriched genes
were involved in immune regulation or response.
Percentages show the ratio of the number of enriched
genes to the number of available genes that could be
enriched within the considered KEGG category or an-
notation cluster.
Hierarchical cluster analysis of differentially
expressed genes between T2DM-SDP patients and
healthy volunteers
We conducted hierarchical cluster analysis of the 175
DEGs between T2DM-SDP patients and healthy vol-
unteers to show the distinguishable gene expression pat-
tern between the two study groups. As shown in Figure
4, the T2DM-SDP patient group (dia1-dia6) and
healthy volunteer group (con1-con6) could be clus-
tered into two separate categories, indicating the exis-
tence of different gene profiles. Thus the gene profiling
could be applied for clinical pattern differentiation be-
tween T2DM-SDP patients and healthy volunteers.
The clustering also revealed that the DEGs of
T2DM-SDP patients tended to be down-regulated
compared with expression in healthy volunteers, which
is consistent with our previous SDP studies in chronic
gastritis.2-4
DISCUSSION
Accumulating clinical evidence suggests that SDP pa-
tients usually manifest with hypoimmunity as well as
dysfunction of the digestive system. White blood cells
are recognized as the most important cells in innate
and specific immunities, and a previous study investi-
gating the differential gene profile of PWBCs in SDP
patients with chronic gastritis and ulcerative colitis con-
cluded that immune dysfunction was responsible for
the occurrence and development of SDP.7 Gene array
studies on SDP are rare, and predominantly focused
on digestive system disease. The present study intro-
duced a non-digestive disease, T2DM, as the object of
study in association with SDP for the first time, and
collected PWBCs as the tissue source for gene array
analysis.
Our findings revealed differential gene profiles of PW-
BCs between T2DM-SDP patients and healthy volun-
teers. We screened a total of 175 DEGs, of which 111
(63%) were down-regulated and 64 (37%) up-regulat-
Figure 2 Volcano plot of differentially expressed genes be-
tween patients of type 2 diabetes mellitus with spleen defi-
ciency pattern and healthy volunteers
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Item
Down
-regulated
Up
-regulated
Gene symbol
ADORA3
C4BPA
CCL23
CCR3
CLEC4C
EGR3
FGFBP2
GZMB
IDO1
IL5RA
IL8
KIR2DL4
KIR2DL5A
KIR2DS2
KIR2DS3
KIR2DS4
KIR3DL1
KIR3DL2
KLF6
MC5R
OLIG2
PBK
PDGFD
PTGDR2
SERPING1
SIGLEC8
TREM1
A1BG
AFF3
BLK
C8orf80
CD200
CLEC17A
CR2
CXCR5
EBF1
FCRL1
FCRL2
MS4A1
PAX5
PLEKHG1
POU2AF1
TCL1A
TNFRSF13C
VNN1
VPREB3
Gene name
Adenosine a3 receptor
Complement component 4 binding protein, alpha
Chemokine (c-c motif ) ligand 23
Chemokine (c-c motif ) receptor 3
C-type lectin domain family 4, member c
Early growth response 3
Fibroblast growth factor binding protein 2
Granzyme b (granzyme 2, cytotoxic t-lymphocyte-associated serine esterase 1)
Indoleamine 2,3-dioxygenase 1
Interleukin 5 receptor, alpha
Interleukin 8
Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4
Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5a
Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3
Killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4
Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
Kruppel-like factor 6
Melanocortin 5 receptor
Oligodendrocyte lineage transcription factor 2
Pdz binding kinase
Platelet derived growth factor d
Prostaglandin d2 receptor 2
Serpin peptidase inhibitor, clade g (c1 inhibitor), member 1
Sialic acid binding ig-like lectin 8
Triggering receptor expressed on myeloid cells 1
Alpha-1-b glycoprotein
Af4/fmr2 family, member 3
B lymphoid tyrosine kinase
Chromosome 8 open reading frame 80
Cd200 molecule
C-type lectin domain family 17, member a
Complement component (3d/epstein barr virus) receptor 2
Chemokine (c-x-c motif ) receptor 5
Early b-cell factor 1
Fc receptor-like 1
Fc receptor-like 2
Membrane-spanning 4-domains, subfamily a, member 1
Paired box 5
Pleckstrin homology domain containing, family g (with rhogef domain)
member 1
Pou class 2 associating factor 1
T-cell leukemia/lymphoma 1a
Tumor necrosis factor receptor superfamily, member 13c
Vanin 1
Pre-b lymphocyte 3
P value
0.0035
0.0095
0.0003
0.0261
0.0143
0.0193
0.0069
0.0083
0.0216
0.0168
0.0107
0.0305
0.0182
0.0463
0.0291
0.0182
0.0321
0.0460
0.0000
0.0046
0.0149
0.0245
0.0000
0.0064
0.0178
0.0141
0.0000
0.0259
0.0019
0.0014
0.0136
0.0016
0.0002
0.0007
0.0001
0.0131
0.0022
0.0014
0.0020
0.0001
0.0131
0.0012
0.0013
0.0001
0.0064
0.0004
Fold
Change
－2.7270
－11.3428
－5.5459
－2.8744
－2.4549
－2.0619
－2.0717
－2.3602
－2.7238
－3.2313
－3.2706
－2.5126
－2.6984
－2.4129
－5.5957
－2.7779
－2.5406
－2.1359
－2.1354
－2.1178
－4.0154
－2.7249
－2.1684
－2.1094
－3.1439
－2.7180
－4.3184
2.8785
2.0534
2.0439
2.0222
2.4096
2.1208
2.0659
2.0886
2.5955
2.0658
2.1055
2.2628
3.2585
2.0192
2.0701
2.2598
2.0250
2.6269
2.3743
Notes: T2DM-SDP: type 2 diabetes mellitus with spleen deficiency pattern; a negative fold-change value indicates down-regulation of the
corresponding gene; a positive value indicates up-regulation.
Table 1 Differentially expressed immunity-related genes between T2DM-SDP patients and healthy volunteers
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ed in T2DM-SDP patients compared with controls.
Of the 158 genes with biological function annotations,
46 were directly related with immune regulation or re-
sponse; 25 were associated with substance and energy
metabolism, which could also indirectly influence im-
munity; and 87 were involved in a variety of processes
that might influence immune functions. Moreover,
KEGG pathway enrichment analysis of the DEGs
found that they were predominantly enriched in im-
mune-related pathways.
Among the 46 DEGs directly related to immune regu-
lation or response, 27 were down-regulated and partici-
pate in a wide variety of immune processes, including
macrophage recruitment,15 neutrophil and monocyte-
mediated inflammatory responses,16 chemotactic activi-
ty on immune cells, e.g. interleukin-8 activity, _EN-
REF_1113,17 lymphocyte development and activation,18
antigen capturing,19 cytotoxic lymphocyte-mediated im-
munity, 20 and complement activation. The down-regu-
lation of these genes could result in impairment of an
individual's innate and specific immunity, thus contrib-
uting to the hypoimmunity of T2DM-SDP patients.
The other 19 genes were up-regulated and are also in-
volved in various immune processes, such as the migra-
tion of T-cell progenitors to the thymus,21 B-cell migra-
tion and activation,22 B-lymphocyte development and
differentiation, and the response of B-cells to antigens.23
The up-regulation of these genes might explain the im-
mune dysfunction of T2DM- SDP patients. Together,
these results suggest that the 46 DEGs are responsible
for the hypoimmunity and / or immune dysfunction
of T2DM-SDP patients observed in clinical practice.
TCM patterns are considered to be pathological sum-
maries of the etiology, location, nature, and tendency
of diseases of certain stages. Moreover, the gene expres-
sion profile reflects current and specific characteristics
of the organism, so it is reasonable to expect connec-
tions between these profiles and TCM patterns in the
clinical diagnosis and classification of disease, as dem-
onstrated in the current study.
The present study has a number of limitations, includ-
ing the fact that microarray findings were not verified
by PCR analysis, PCR verifications of the differential
genes were not performed, the small sample sizes, and
the restricted tissue sources available for gene array.
These issues warrant attention in future studies focus-
ing on SDP.
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Figure 4 Hierarchical cluster analysis
dia1-dia6: patients of type 2 diabetes mellitus with spleen
deficiency pattern; con1-con6: healthy volunteers. Green in-
dicates down-regulation of the corresponding gene, and
red indicates up-regulation.
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